Free Trial
NASDAQ:SOPH

SOPHiA GENETICS (SOPH) Stock Price, News & Analysis

SOPHiA GENETICS logo
$2.95 +0.06 (+2.11%)
As of 10:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About SOPHiA GENETICS Stock (NASDAQ:SOPH)

Key Stats

Today's Range
$2.83
$2.98
50-Day Range
$2.66
$3.68
52-Week Range
$2.58
$6.28
Volume
11,917 shs
Average Volume
61,127 shs
Market Capitalization
$196.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.80
Consensus Rating
Moderate Buy

Company Overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

SOPHiA GENETICS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

SOPH MarketRank™: 

SOPHiA GENETICS scored higher than 36% of companies evaluated by MarketBeat, and ranked 721st out of 917 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SOPHiA GENETICS has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    SOPHiA GENETICS has received no research coverage in the past 90 days.

  • Read more about SOPHiA GENETICS's stock forecast and price target.
  • Earnings Growth

    Earnings for SOPHiA GENETICS are expected to grow in the coming year, from ($0.96) to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SOPHiA GENETICS is -2.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SOPHiA GENETICS is -2.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about SOPHiA GENETICS's valuation and earnings.
  • Percentage of Shares Shorted

    0.08% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 8.69%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SOPHiA GENETICS does not currently pay a dividend.

  • Dividend Growth

    SOPHiA GENETICS does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.08% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 8.69%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    Only 1 people have added SOPHiA GENETICS to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SOPHiA GENETICS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.88% of the stock of SOPHiA GENETICS is held by insiders.

  • Percentage Held by Institutions

    Only 31.59% of the stock of SOPHiA GENETICS is held by institutions.

  • Read more about SOPHiA GENETICS's insider trading history.
Receive SOPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter.

SOPH Stock News Headlines

This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
See More Headlines

SOPH Stock Analysis - Frequently Asked Questions

SOPHiA GENETICS's stock was trading at $3.07 at the beginning of the year. Since then, SOPH shares have decreased by 5.9% and is now trading at $2.89.
View the best growth stocks for 2025 here
.

SOPHiA GENETICS SA (NASDAQ:SOPH) posted its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.05. The firm earned $17.78 million during the quarter, compared to the consensus estimate of $16.76 million. SOPHiA GENETICS had a negative net margin of 110.71% and a negative trailing twelve-month return on equity of 55.06%.
Read the conference call transcript
.

SOPHiA GENETICS (SOPH) raised $234 million in an initial public offering (IPO) on Friday, July 23rd 2021. The company issued 13,000,000 shares at $17.00-$19.00 per share.

SOPHiA GENETICS's top institutional investors include UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC (11.45%), Banque Pictet & Cie SA (3.32%), Principal Financial Group Inc. (2.08%) and Bank Pictet & Cie Europe AG (0.38%).

Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SOPHiA GENETICS investors own include Occidental Petroleum (OXY), PayPal (PYPL), Chesapeake Energy (CHK), Cheniere Energy (LNG), Rocket Pharmaceuticals (RCKT), AbCellera Biologics (ABCL) and Farmers & Merchants Bancorp (FMAO).

Company Calendar

Last Earnings
5/06/2025
Today
5/23/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SOPH
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.80
High Stock Price Target
$11.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+135.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-78,980,000.00
Net Margins
-110.71%
Pretax Margin
-109.76%

Debt

Sales & Book Value

Annual Sales
$67.17 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
62,185,000
Market Cap
$192.73 million
Optionable
Not Optionable
Beta
1.03
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SOPH) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners